Provectus Biopharmaceuticals (PVCT) to Discuss Phase 3 Clinical Trial Of PV-10
Tweet Send to a Friend
Provectus Biopharmaceuticals, Inc. (NYSE: PVCT), announced today that it will hold a conference call on Thursday, June 19, 2014, at ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
